31
1
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP2160L1 |
YAP-TEAD-IN-1 acetate
YAP-TEAD-IN-1 acetate (1659305-78-8 Free base) |
YAP | Stem Cells |
YAP-TEAD-IN-1 acetate 是一种有效的、竞争性的 YAP-TEAD 相互作用抑制剂,IC50 为 25 nM。 | |||
T77725 |
YAP-TEAD-IN-3
IAG933 |
YAP | Stem Cells |
YAP-TEAD-IN-3 是 YAP/TAZ-TEAD 相互作用的抑制剂,对于 Avi-人 TEAD4217-434 的 IC50 为 9 nM。 YAP-TEAD-IN-3 抑制 YAP 报告基因表达 (IC50 = 0.048 μM) 和 NCI-H2052 细胞增殖 (IC50 = 0.048 μM)。 | |||
TP2160 |
YAP-TEAD-IN-1
|
Others | Others |
YAP-TEAD-IN-1 is a competitive inhibitor of YAP–TEAD interaction (IC50: 25 nM). It shows a higher binding affinity to TEAD1 (Kd: 15 nM) than YAP (50-171) (Kd: 40 nM). | |||
TP2160L |
YAP-TEAD-IN-1 TFA
|
Others | Others |
YAP-TEAD-IN-1 TFA is a competitive inhibitor of YAP–TEAD interaction (IC50: 25 nM). It shows a higher binding affinity to TEAD1 (Kd: 15 nM) than YAP (50-171) (Kd: 40 nM). | |||
T83951 |
TM2 TEAD inhibitor
|
Others | Others |
TM2 TEAD抑制剂是一种有效并且可逆的TEA领域转录因子抑制剂(IC50为TEAD4自动棕榈酰化和TEAD2棕榈酰化分别为38 nM和156 nM)。它抑制TEAD-YAP的结合和转录活性。TM2 TEAD抑制剂在YAP依赖型癌症细胞中,无论是单独使用还是与MEK抑制剂联合使用,都显示出强大的抗增殖效果。同时抑制体外YAP依赖的肝脏类器官生长。 | |||
T61776 |
TEAD-IN-2
|
Others | Others |
TEAD-IN-2 is an innovative, orally bioavailable inhibitor that targets the transcriptional enhancer associate domain (TEAD). It functions by regulating TEAD through ubiquitination and/or degradation by specific compounds. This compound, TEAD-IN-2, holds potential for studying various diseases, disorders, or conditions linked to TEAD [1]. | |||
T79687 |
TEAD-IN-6
|
YAP | Stem Cells |
TEAD-IN-6(Example 11-1),一种TEAD调节剂,具有阻断YAP1/TAZ与TEAD相互作用的活性,适用于癌症研究领域。 | |||
T62597 |
TEAD-IN-3
|
Others | Others |
TEAD-IN-3 (compound I-177) 是一种 TEAD 转录因子的有效抑制剂。TEAD-IN-3 能够用于增生性疾病的研究,如癌症。 | |||
T72888 | YAP-TEAD-IN-2 | YAP | Stem Cells |
YAP-TEAD-IN-2 (化合物6)作为一种YAP-TEAD PPI抑制剂,表现出高效性,其半抑制浓度(IC50)仅为2.7 nM。 | |||
T8421 |
TED-347
|
YAP | Stem Cells |
TED-347 是不可逆的、共价的 YAP-TEAD 蛋白质-蛋白质相互作用变构抑制剂,对 TEAD4•Yap1 蛋白质-蛋白质相互作用的 EC50为 5.9 μM。它与 TEAD4 中央口袋内的 Cys-367 特异性共价结合(Ki:10.3 μM)。它可以抑制 TEAD 的转录活性,并且具有抗肿瘤作用。 | |||
T9032 |
MGH-CP1
|
Others | Others |
MGH-CP1 是 TEAD2 (IC50:710 nM) 及 TEAD4 (IC50:672 nM) 自棕榈酰化抑制剂,口服有活性,可降低细胞内源性或异位表达的 TEAD 蛋白棕榈酰化水平。MGH-CP1 与 Lats1/2 缺失,是 Myc 的表达受到抑制,阻碍上皮细胞过度增殖,诱导细胞凋亡。 | |||
T9954 |
K-975
|
Others | Others |
K-975是一种高选择性的具有口服活性的TEAD 抑制剂,可有效抑制TEAD 和YAP1/TAZ 之间的蛋白质-蛋白质相互作用。 | |||
T22372 |
MYF-01-37
1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one |
Others; YAP | Others; Stem Cells |
MYF-01-37 (1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one) 是共价TEAD 抑制剂,靶向 Cys380,能够可逆地抑制 YAP/TEAD 相互作用。 | |||
T64342 |
DC-TEADin02
|
YAP | Stem Cells |
DC-TEADin02 是 TEAD 自棕榈酰化抑制剂 (IC50 = 197 nM)。 DC-TEADin02 可用于有关发育、再生和组织稳态的研究。 | |||
T77580 |
IK-930
compound I-32 |
YAP | Stem Cells |
IK-930 是一种具有口服活性 TEAD 抑制剂(EC50 < 0.1 µM)具有强效性。 | |||
T35545 |
VT107
|
YAP | Stem Cells |
VT107 是一种强效的泛 TEAD 自身棕榈酰化抑制剂。VT-107 可用于癌症研究。 | |||
T62077 |
VT103
VT-103,VT 103 |
YAP | Stem Cells |
VT103 是一种具有口服活性和选择性的 TEAD1 蛋白棕榈酰化抑制剂,是 VT101 的类似物。 VT103 有潜在的抗肿瘤活性,可抑制 YAP/TAZ-TEAD 促进的基因转录,阻断 TEAD auto-palmitoylation,阻断 YAP/TAZ和TEAD 之间的相互作用。VT103 可用于研究HER2阳性乳腺癌、前列腺癌和三阴性乳腺癌。 | |||
T69760 |
TT-10
TAZ-K |
YAP | Stem Cells |
TT-10 (TAZ-K) 作为YES相关蛋白(YAP)-转录增强因子结构域(TEAD)活性的激活剂,适用于心肌细胞丢失伴随心脏病研究。 | |||
T69638 |
VT-105
VT 105 |
Others | Others |
VT-105 是一种强效的选择性 TEAD 自棕榈酰化抑制剂,可抑制 NF2 缺陷间皮瘤的增殖和肿瘤生长。 | |||
T78558 |
GNE-7883
GNE 7883,GNE7883 |
YAP | Stem Cells |
GNE-7883是一种靶向 TEAD 转录因子的抑制剂,抑制细胞增殖,抑制YAP/TAZ的激活,可用于研究YAP/TAZ依赖型肿瘤。 | |||
T3112 |
Verteporfin
维替泊芬,BPD-MA,CL 318952 |
Apoptosis; YAP; VDA; Autophagy | Angiogenesis; Apoptosis; Autophagy; Stem Cells |
Verteporfin (BPD-MA) 是一种 YAP 抑制剂,抑制 YAP-TEAD 相互作用。Verteporfin 也是一种光敏剂,用于光动力疗法。Verteporfin 还可以诱导细胞凋亡,抑制自噬。 | |||
T60148 |
MSC-4106
|
YAP | Stem Cells |
MSC-4106 是一种有效的、具有口服活性的 YAP/TAZ-TEAD 抑制剂。 MSC-4106 阻断 TEAD1 和 TEAD3 的自棕榈酰化,并且对 NCI-H226 异种移植瘤模型显示抑制作用。 | |||
T60218 |
YAP/TAZ inhibitor-2
|
YAP | Stem Cells |
YAP/TAZ inhibitor-2 是一种有效的具有口服活性的TEAD-YAP/TAZ 抑制剂,EC50值为 3 nM。YAP/TAZ inhibitor-2 具有抗增殖和抗肿瘤活性。 | |||
T81056 |
SWTX-143
|
YAP | Stem Cells |
SWTX-143,一新型共价YAP/TAZ-TEAD 抑制剂,能结合四种TEAD亚型的棕榈酰化口袋。SWTX-143特异性、不可逆地抑制YAP/TAZ-TEAD转录活性,表现出抗肿瘤活性。 | |||
T79427 |
LM-41
|
YAP | Stem Cells |
LM-41是一种衍生自Flufenamic acid的TEAD抑制剂,能有效下调CTGF、Cyr61、Axl和NF2的表达水平。此外,LM-41抑制了人类MDA-MB-231乳腺癌细胞的迁移。 | |||
T79428 |
AF-2112
|
YAP | Stem Cells |
AF-2112为Flufenamic acid衍生物,作为TEAD抑制剂,能显著抑制CTGF、Cyr61、Axl及NF2基因表达。 | |||
T68934 |
VT101 free base
|
Others | Others |
VT101 is a TEAD Auto-palmitoylation inhibitor that Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. VT101 inhibited the firefly luciferase reporter dose-dependently and had no 204 effect on the Renilla luciferase reporter. | |||
T76005 |
Super-TDU (1-31)
|
||
Super-TDU (1-31) 是 Super-TDU 的肽片段。Super-TDU (1-31) 是 YAP-TEAD 复合物的抑制剂。Super-TDU 在胃癌小鼠模型中显示出有效的抗肿瘤活性并抑制肿瘤生长。 | |||
T71424 |
VT-102 free base
|
Others | Others |
VT-102 is a TEAD Auto-palmitoylation inhibitor that Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. VT102 inhibited the firefly luciferase reporter dose-dependently and had no 204 effect on the Renilla luciferase reporter. | |||
T76005L |
Super-TDU (1-31) (TFA)
|
||
Super-TDU (1-31) TFA 是 Super-TDU 的肽片段。Super-TDU (1-31) TFA 是YAP-TEAD 复合物的抑制剂。Super-TDU TFA 在胃癌小鼠模型中显示出有效的抗肿瘤活性并抑制肿瘤生长。 | |||
T76004 |
Super-TDU TFA
|
||
Super-TDU TFA 是一种特异性的 YAP 拮抗剂,可以靶向 YAP-TEAD 相互作用。Super-TDU TFA 可以抑制胃癌小鼠模型的肿瘤生长。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1679 |
Thiostrepton
Thiactin,Bryamycin,Alaninamide,硫链丝菌素 |
DNA/RNA Synthesis; Antibacterial; Antibiotic | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
Thiostrepton (Alaninamide) 是一种选择性抑制FOXM1的抗生素。FOXM1会与 YAP/TEAD 复合物结合,形成YAP/TEAD/FOXM1 复合物。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02943 |
TEAD4 Protein, Mouse, Recombinant
TEA domain family member 4,TEF-1-related factor 1,Tead |
Mouse | E. coli |
TEAD4 Protein, Mouse, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 25.7 kDa and the accession number is Q62296. | |||
TMPH-02223 |
TEAD4 Protein, Human, Recombinant (His)
Transcription factor 13-like 1,Transcription factor RTEF-1,T... |
Human | E. coli |
TEAD4 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 44.7 kDa and the accession number is Q15561. | |||
TMPH-02222 |
TEAD1 Protein, Human, Recombinant (His)
TEAD1,Transcriptional enhancer factor TEF-1,Transcr... |
Human | E. coli |
Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expr... | |||
TMPH-02225 |
TEAD2 Protein, Human, Recombinant (His & Myc)
TEA domain family member 2,Transcriptional enhancer factor T... |
Human | E. coli |
Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expr... | |||
TMPH-02942 |
TEAD4 Protein, Mouse, Recombinant (His & Myc)
TEF-1-related factor FR-19,TEF-1-related factor 1,TEA domain... |
Mouse | E. coli |
TEAD4 Protein, Mouse, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 33.0 kDa and the accession number is Q62296. | |||
TMPH-02224 |
TEAD4 Protein, Human, Recombinant (His & Myc)
Transcription factor 13-like 1,TEA domain family member 4,Tr... |
Human | Baculovirus Insect Cells |
TEAD4 Protein, Human, Recombinant (His & Myc) is expressed in Baculovirus insect cells with N-10xHis and C-Myc tag. The predicted molecular weight is 44.5 kDa and the accession number is Q15561. | |||
TMPH-02226 |
TEAD3 Protein, Human, Recombinant (His & SUMO)
DTEF-1,TEA domain family member 3,Transcriptional enhancer f... |
Human | E. coli |
Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expr... | |||
TMPH-03764 |
YAP1 Protein, Human, Recombinant (His)
YAP1-2gamma,YAP2L,YAP65 |
Human | P. pastoris (Yeast) |
Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1,... |